# Nadroparin for the Initial Treatment of Pulmonary Thromboembolism

> **NCT00796692** · PHASE4 · COMPLETED · sponsor: **Beijing Chao Yang Hospital** · enrollment: 274 (actual)

## Conditions studied

- Pulmonary Embolism
- Thromboembolism
- Vascular Diseases
- Thrombosis

## Interventions

- **DRUG:** Nadroparin
- **DRUG:** Unfractionated heparin(UFH)

## Key facts

- **NCT ID:** NCT00796692
- **Lead sponsor:** Beijing Chao Yang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 274 (ACTUAL)
- **Last updated:** 2008-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796692, "Nadroparin for the Initial Treatment of Pulmonary Thromboembolism". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00796692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*